Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
- PMID: 26305549
- PMCID: PMC4694886
- DOI: 10.18632/oncotarget.4569
Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
Abstract
While B cells in the tumor microenvironment may play important roles in cancer progression, their impacts on the bladder cancer (BCa) metastasis remain unclear. Here we found from human clinical BCa samples that BCa tissues could recruit more B cells than the surrounding normal bladder tissues and the in vitro co-culture assay also demonstrated that B cells could be recruited more easily towards BCa cells compared to normal bladder cells. Chamber invasion and 3D invasion assays showed the recruited B cells could then significantly increase the BCa cell invasion. Mechanism dissection found that recruited B cells could increase IL-8/androgen receptor (AR) signals in BCa cells that could then promote the expression of metastasis genes including MMP1 and MMP13. Blocking the IL-8/AR/MMPs signals either by anti-IL-8 neutralizing antibody, AR-siRNA, or MMPs inhibitors all partially reversed the infiltrating B cells capacity to increase the BCa cell invasion. The in vivo data from orthotopically xenografted BCa mouse model also confirmed that infiltrating B cells could increase BCa cell invasion via increasing AR signals. Together, these results demonstrate the key roles of B cells within the bladder tumor microenvironment that increase the BCa metastasis and may help us to develop the potential therapies via targeting these newly identified IL-8/AR/MMPs signals to better battle the BCa progression.
Keywords: B cell; androgen receptor; bladder cancer; tumor metastasis; tumor microenvironment.
Figures
Similar articles
-
Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.Oncotarget. 2015 Dec 15;6(40):43081-9. doi: 10.18632/oncotarget.5638. Oncotarget. 2015. PMID: 26517808 Free PMC article.
-
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.Cell Death Differ. 2021 Jul;28(7):2145-2159. doi: 10.1038/s41418-021-00743-w. Epub 2021 Jun 14. Cell Death Differ. 2021. PMID: 34127806 Free PMC article.
-
Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.Cancer Lett. 2018 Aug 28;430:215-223. doi: 10.1016/j.canlet.2018.03.045. Epub 2018 Apr 22. Cancer Lett. 2018. PMID: 29684419
-
Androgen receptor modulation and bladder cancer prevention - a short review.Med Pr. 2022 Apr 22;73(2):151-162. doi: 10.13075/mp.5893.01229. Epub 2022 Mar 14. Med Pr. 2022. PMID: 35283486 Review.
-
The androgen receptor in bladder cancer.Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18. Nat Rev Urol. 2023. PMID: 37072491 Review.
Cited by
-
Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma.Transl Cancer Res. 2024 Jan 31;13(1):150-172. doi: 10.21037/tcr-23-1383. Epub 2024 Jan 15. Transl Cancer Res. 2024. PMID: 38410230 Free PMC article.
-
Roles of Androgen Receptor Signaling in Urothelial Carcinoma.Cancers (Basel). 2024 Feb 10;16(4):746. doi: 10.3390/cancers16040746. Cancers (Basel). 2024. PMID: 38398136 Free PMC article. Review.
-
Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer.J Transl Med. 2024 Jan 12;22(1):48. doi: 10.1186/s12967-024-04860-1. J Transl Med. 2024. PMID: 38216927 Free PMC article.
-
Identification of novel serum protein biomarkers in the context of 3P medicine for intravenous leiomyomatosis: a data-independent acquisition mass spectrometry-based proteomics study.EPMA J. 2023 Sep 4;14(4):613-629. doi: 10.1007/s13167-023-00338-0. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094583
-
CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer.Cancers (Basel). 2023 Nov 22;15(23):5529. doi: 10.3390/cancers15235529. Cancers (Basel). 2023. PMID: 38067231 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007;99:558–568. - PubMed
-
- Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer. 2012;130:1109–1119. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
